Rappel de l'avis de la Commission d

Rappel de l'avis de la Commission du 26 avril 2006 : Le service médical rendu par cette spécialité est important. Duodopa apporte une amélioration du service médical rendu mineure (niveau IV) en termes d'efficacité chez les patients parkinsoniens en échec des autres thérapeutiques médicamenteuses. Réévaluation du niveau d'amélioration du service médical rendu : La prise en compte des données déposées ne permet pas de modifier l'avis précédent de la Commission.

결과 (영어) 1:

Reminder of the opinion of the Committee on April 26, 2006: medical service rendered by this specialty is important. Duodopa brings an improvement of minor rendering medical service (level IV) in terms of efficiency in parkinsonian patients with failure of other drug therapies. Reassessment of the level of improvement of the medical service provided: taking account of the deposited data does not change the previous opinion of the Committee.

결과 (영어) 2:

Recall the opinion of the Commission of 26 April 2006: The actual benefit of this product is substantial. Duodopa provides a minor improvement in actual benefit (level IV) in terms of efficacy in PD patients failing other drug treatments. Reassessment of the level of improvement in rendering medical service: Consideration registered data does not change the previous opinion of the Commission.

결과 (영어) 3:

Reminder of the opinion of the Commission of the April 26, 2006: The medical service rendered by this specialty is important. Duodopa made an improvement of the medical service rendered minor (level IV) in terms of efficiency among parkinsonian patients in failure of other medicinal therapeutic. Reassessment of the level of improvement of the medical service rendered:The taking into account of the data submitted does not allow to modify the previous opinion of the Commission.